阅读说明：本技术 唐古特铁线莲中皂苷类化学对照品的分离制备工艺及其应用 (Separation and preparation process and application of saponin chemical reference substance in clematis tangutica ) 是由 卫阳飞 陈涛 王硕 李玉林 申诚 赵景阳 孔令繁 杨丽 丁永渊 于 2021-07-27 设计创作，主要内容包括：本发明涉及化学对照品的制备和应用技术领域,具体涉及唐古特铁线莲中皂苷类化学对照品的分离制备工艺及其应用。具体制备工艺为提取、正丁醇粗富集、大孔树脂精细富集、高速逆流色谱分离及结构鉴定。本发明方法将大孔树脂和高速逆流色谱技术相结合,通过优化富集和分离条件,建立了唐古特铁线莲中7种结构类似的齐墩果烷型皂苷类化学对照品的高效分离制备工艺,操作简单、方便、易于实现自动化控制,具有重复性和稳定性好的优点,非常适合唐古特铁线莲中7种皂苷类化学对照品的制备,对于天然产物中皂苷类化学对照品的制备具有重要的参考价值。本发明提供的齐墩果烷型三萜皂苷类化学对照品可作为抗肿瘤药物的先导性化合物,有良好的应用前景。(The invention relates to the technical field of preparation and application of chemical reference substances, in particular to a separation preparation process and application of a saponin chemical reference substance in tangut clematis. The specific preparation process comprises extraction, n-butanol crude enrichment, macroporous resin fine enrichment, high-speed counter-current chromatographic separation and structure identification. The method combines macroporous resin and high-speed countercurrent chromatography, establishes a high-efficiency separation preparation process of 7 oleanane type saponin chemical reference substances with similar structures in the tangut clematis by optimizing enrichment and separation conditions, has the advantages of simple and convenient operation, easy realization of automatic control and good repeatability and stability, is very suitable for preparing the 7 saponin chemical reference substances in the tangut clematis, and has important reference value for preparing the saponin chemical reference substances in natural products. The oleanane-type triterpenoid saponin chemical reference substance provided by the invention can be used as a guiding compound of an anti-tumor medicament, and has a good application prospect.)

1. The separation and preparation process of the saponin chemical reference substance in the tangut clematis is characterized by comprising the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: heating and refluxing 5-30 mL of ethanol with volume concentration of 60-95% at an extraction temperature of 60-90 ℃, wherein the extraction times are 1-4 times and each time is 1-4 hours, combining the extracting solutions, and performing reduced pressure concentration and freeze drying to obtain a crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, firstly, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, then extracting with 1-5 times of n-butanol for 1-5 times, collecting all n-butanol extract, concentrating under reduced pressure, and freeze drying to obtain a crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into a solution of 7.5-60 mg/mL by using pure water, loading the solution on a macroporous resin column at a flow rate of 1-5 BV/h, repeatedly loading the effluent liquid on the column for 1-5 times, and standing for 2-12 h; removing impurities, and eluting for 1-8 BV by adopting 0-40% ethanol at a flow rate of 1-5 BV/h; enriching, namely selecting 2-4 ethanol concentrations from 30-90% ethanol, eluting for 1-8 BV at the flow rate of 1-5 BV/h respectively to obtain 2-4 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 2-4 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponins, and respectively separating by high-speed countercurrent chromatography to obtain 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G and hederasporin B; 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylhexetigenin 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester, and neosaponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures; the chemical structural formulas of the 7 saponins chemical reference substances are as follows in sequence:

3-O-β-D-allopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosylhederagenin28-O-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl ester。

2. the process for separating and preparing a saponin chemical reference substance in clematis tangutica according to claim 1, wherein the macroporous resin in step 3 is any one of HPD-100, X-5, HPD-400, AB-8, HPD-450 and ADS-7.

3. The separation and preparation process of the chemical reference substance of saponins in clematis tangutica according to claim 1, wherein in the high-speed countercurrent chromatography separation in the step 4, a solvent system is adopted, wherein the solvent system is ethyl acetate-n-butanol-water (1-4: 1-4), v: v: v, the rotation speed of a main machine is 600-1000 rpm, the separation temperature is 25-40 ℃, the flow rate of a mobile phase is 1-4 mL/min, and a head-tail or tail-head separation mode is adopted.

4. The separation and preparation process of the chemical reference substance of saponins in clematis tangutica according to claim 1, wherein in the step of high-speed countercurrent chromatography separation in the step 4, an evaporative light scattering detector ELSD is adopted for detection, wherein the temperature of an atomizer is 60-90 ℃, and the flow rate of carrier gas is 2.5L/min; and a self-made diverter valve system is adopted to realize fractionation, and the self-made diverter valve system consists of a three-way valve and a fine adjustment valve positioned at a sample collection end, wherein the pipe diameter of the sample collection end is 1/16-1/4 inches, and the pipe diameter of the sample detection end is 100-500 mu m.

5. The application of the saponin chemical reference substance in the tangut clematis is characterized in that the saponin chemical reference substance prepared by the claim has the inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to antitumor drugs.

6. The use of saponin chemical reference substance in clematis tangutica according to claim 5, wherein the prepared new saponin chemical reference substance 3-O- β -D-allopyranosyl (1 → 3) - α -L-rhamnopyranosyl (1 → 2) - α -L-arabinopyranosyl 28-O- α -L-rhamnopyranosylphenyl (1 → 4) - β -D-glucopyranosyl (1 → 6) - β -D-glucopyranosyl ester and known saponin Hederaichioside F have selective inhibitory activity against gastric cancer cell HGC-27, IC₅₀Values of 20.17. mu.M and 66.18. mu.M, respectively; the saponin Hederaponin B is known to have broad-spectrum inhibitory effect on gastric cancer cell HGC-27, cervical cancer cell Hela and ovarian cancer cell SK-OV-3, IC₅₀16.4. mu.M, 71.3. mu.M and 64.4. mu.M, respectively; saponin Tauroside St-H₁Has selective inhibitory activity on ovarian cancer cell strain SK-OV-3, IC₅₀48.70 μ M; the 7 separated saponin chemical reference substances have no toxicity to normal gastric mucosa epithelial cell GES-1, and IC₅₀>150 mu M; can be used as effective component in antitumor drug for resisting gastric cancer, cervical cancer or ovarian cancer.

7. The use of the saponins of clematis tangutica according to claim 6, wherein the gastric cancer cell HGC-27, cervical cancer cell Hela, ovarian cancer cell SK-OV-3 are purchased from GmbH, and normal gastric mucosal epithelial cell GES-1 is purchased from Beiner's Biocellulary.

Technical Field

The invention relates to the technical field of preparation and application of chemical reference substances, in particular to a separation preparation process and application of a saponin chemical reference substance in tangut clematis.

Background

Nelumbo tangutica (Clematis tangutica (Maxim.) Korsh) is a perennial herb of the genus Nelumbo of the family Ranunculaceae. The Tibetan medicine documents describe that the medicine has the functions of breaking lump and tumor accumulation, proliferating stomach fire, promoting blood circulation and removing blood stasis and the like, and can be used for treating diseases such as dyspepsia, lump tumor, cold tumor, yellow water disease, edema and the like. The pharmacological action of the tangut clematis is not very different from the abundant saponin components, but the effective components of the tangut clematis playing the anti-tumor role are not clear.

Saponins are compounds rich in various biological activities, but have strong polarity, weak ultraviolet absorption, surfactant property and easy occurrence of emulsification phenomenon, so that great challenges are brought to separation of saponins compounds. Due to the complexity of the natural product components, it is difficult to isolate high purity compounds directly from crude extracts, and it is therefore necessary to enrich the target fraction prior to isolation. The macroporous resin column chromatography has the advantages of good technical repeatability, high adsorption capacity, low operation cost, low solvent consumption, no chemical residue in the product, convenient regeneration and the like, and is an effective means for enriching compounds. In the aspect of separation, the high-speed countercurrent chromatography is carrier-free liquid-liquid partition chromatography, overcomes the defects of sample adsorption, loss, pollution, peak shape tailing and the like caused by the traditional silica gel column chromatography, has obvious advantages in separation for compounds which are difficult to separate by the silica gel column chromatography and have similar structures and similar polarities, and also has the characteristics of large sample loading amount, high recovery rate, high efficiency, good reproducibility and the like. Therefore, the saponin compounds can be well enriched and separated by adopting macroporous resin and high-speed countercurrent chromatography. At present, no report of using macroporous resin and high-speed counter-current chromatography for enriching and separating sapogenin compounds in tangut clematis is available.

Disclosure of Invention

Based on the technical problems, the invention separates 7 oleanane type saponin chemical reference substances with similar structures from the tangut clematis by adopting macroporous resin and high-speed countercurrent chromatography, and carries out the evaluation of the tumor cell inhibition activity and the toxicity evaluation on normal cells. Aims to provide a separation preparation process and application of a saponin chemical reference substance in the tangut clematis.

The invention provides a separation preparation process for a saponin chemical reference substance in tangut clematis, which comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: heating and refluxing 5-30 mL of ethanol with volume concentration of 60-95% at an extraction temperature of 60-90 ℃, wherein the extraction times are 1-4 times and each time is 1-4 hours, combining the extracting solutions, and performing reduced pressure concentration and freeze drying to obtain a crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, firstly, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, then extracting with 1-5 times of n-butanol for 1-5 times, collecting all n-butanol extract, concentrating under reduced pressure, and freeze drying to obtain a crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into a solution of 7.5-60 mg/mL by using pure water, loading the solution on a macroporous resin column at a flow rate of 1-5 BV/h, repeatedly loading the effluent liquid on the column for 1-5 times, and standing for 2-12 h; removing impurities, and eluting for 1-8 BV by adopting 0-40% ethanol at a flow rate of 1-5 BV/h; enriching, namely selecting 2-4 ethanol concentrations from 30-90% ethanol, eluting for 1-8 BV at the flow rate of 1-5 BV/h respectively to obtain 2-4 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 2-4 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponins, and respectively separating by high-speed countercurrent chromatography to obtain 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin monomer compounds through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin g; hederapasonin B; 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylhexetigenin 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester, and neosaponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures; the chemical structural formulas of the 7 saponins chemical reference substances are as follows in sequence:

Hederacholichiside F

Tanguticoside B

Tauroside St-H₁

Hederoside H₁

kalopanaxsaponin G

Hederasaponin B

3-O-β-D-allopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosylhederagenin28-O-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl ester。

further, the macroporous resin in the step 3 is any one of HPD-100, X-5, HPD-400, AB-8, HPD-450 and ADS-7.

Further, in the high-speed counter-current chromatography separation in the step 4, an ethyl acetate-n-butanol-water ratio is 1-4: 1-4, v: v: v, the rotation speed of a main engine is 600-1000 rpm, the separation temperature is 25-40 ℃, the flow rate of a mobile phase is 1-4 mL/min, and a head-tail or tail-head separation mode is adopted.

Further, in the high-speed counter-current chromatography separation step in the step 4, an evaporative light scattering detector ELSD is adopted for detection, wherein the temperature of an atomizer is 60-90 ℃, and the flow rate of carrier gas is 2.5L/min; and a self-made diverter valve system is adopted to realize fractionation, and the self-made diverter valve system consists of a three-way valve and a fine adjustment valve positioned at a sample collection end, wherein the pipe diameter of the sample collection end is 1/16-1/4 inches, and the pipe diameter of the sample detection end is 100-500 mu m. When the micro-regulating valve is in a fully relaxed state, no pressure exists at the collecting end, and the liquid cannot enter the evaporative light scattering detector ELSD because the pipe diameter of the collecting end is far larger than that of the detecting end; the micro-adjusting valve at the sample collecting end is properly screwed, so that the pressure at the collecting end can be improved, the flow distribution proportion is controlled, and the purposes of detection and collection are achieved.

The invention also protects the application of the saponin chemical reference substance in the tangut clematis, and the prepared saponin chemical reference substance has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to antitumor drugs.

Further, the prepared novel saponin 3-O- β -D-allopyranosyl (1 → 3) - α -L-rhamnopyranosyl (1 → 2) - α -L-arabinopyranosylheiderigenin 28-O- α -L-rhamnopyranosyl (1 → 4) - β -D-glucopyranosyl (1 → 6) - β -D-glucopyranosyl ester and known saponin Hederechoroside F have selective inhibitory activity on gastric cancer cell HGC-27, IC is IC-C-27₅₀Values of 20.17. mu.M and 66.18. mu.M, respectively; the saponin Hederaponin B is known to have broad-spectrum inhibitory effect on gastric cancer cell HGC-27, cervical cancer cell Hela and ovarian cancer cell SK-OV-3, IC₅₀16.4. mu.M, 71.3. mu.M and 64.4. mu.M, respectively; saponin Tauroside St-H₁Has selective inhibitory activity on ovarian cancer cell strain SK-OV-3, IC₅₀48.70 μ M; the 7 separated saponin chemical reference substances have no toxicity to normal gastric mucosa epithelial cell GES-1, and IC₅₀>150 mu M; can be used as effective component in antitumor drug for resisting gastric cancer, cervical cancer or ovarian cancer.

Further, the gastric cancer cell HGC-27, the cervical cancer cell Hela and the ovarian cancer cell SK-OV-3 are purchased from Wuhan Pronociose Life technologies GmbH, and the normal gastric mucosal epithelial cell GES-1 is purchased from Beinana biological cell bank.

Compared with the prior art, the invention has the following beneficial effects:

(1) the method combines macroporous resin and high-speed countercurrent chromatography, establishes a high-efficiency separation preparation process of 7 oleanane type saponin chemical reference substances with similar structures in the tangut clematis by optimizing enrichment and separation conditions, has the advantages of simple and convenient operation, easy realization of automatic control, good repeatability and good stability, is very suitable for preparing the 7 saponin chemical reference substances in the tangut clematis, and has important reference value for preparing the saponin chemical reference substances in natural products.

(2) The first isolated oleanane saponin reference of the present invention is the new chemical reference 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylheiferin 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester and the known saponins Hederacathariside F, Hederaponin B and Tauroside St-H₁Has antitumor effect. The oleanane-type triterpenoid saponin chemical reference substance provided by the invention can be used as a guiding compound of an anti-tumor medicament, and has a good application prospect.

Drawings

FIG. 1 is a diagram of HSCCC separation of a finely enriched product group 1 according to the present invention;

FIG. 2 is a diagram of HSCCC separation of the finely enriched product group 2 of the present invention

FIG. 3 is a UPLC chromatogram of the finely enriched product group 1 of the present invention;

FIG. 4 is a UPLC chromatogram of the finely enriched product group 2 of the present invention;

FIG. 5 is a purity test chart of saponin chemical reference I Hederachholyside F prepared by the method of the present invention;

FIG. 6 is a purity detection chart of a saponin chemical reference substance II Tangutoside B prepared by the method of the invention;

FIG. 7 shows saponin chemical reference III Tauroside St-H prepared by the method of the present invention₁A purity detection map of (a);

FIG. 8 is a diagram showing the purity of IV 3-O- β -D-allopyranosyl (1 → 3) - α -L-rhamnopyranosyl (1 → 2) - α -L-arabinopyranosylhexetil 28-O- α -L-rhamnopyranosyl (1 → 4) - β -D-glucopyranosyl (1 → 6) - β -D-glucopyranosyl ester, a novel saponin-based chemical control prepared by the method of the present invention;

FIG. 9 shows a saponin chemical reference V Hederoside H prepared by the method of the invention₁A purity detection map of (a);

FIG. 10 is a graph showing the purity of a saponin chemical control, VI kalopanaxsaponin G, prepared by the method of the present invention;

FIG. 11 is a purity test chart of a saponin chemical reference VII Hederaponin B prepared by the method of the present invention;

FIG. 12 shows the HMBC and NOESY results for the new saponin chemical control made by the method of the present invention.

FIG. 13 is a flow diagram of a self-made diverter valve system and overall process in the process of the present invention;

FIG. 14 shows the adsorption capacity of different macroporous resins on Nothapodytes catfish saponin (A)_e) And desorption rate (D)_d)；

FIG. 15 is a graph of the effect of loading concentration on the enrichment process;

FIG. 16 is a graph of the effect of ethanol concentration on enrichment;

FIG. 17 is the effect of elution volume on enrichment effect.

Wherein, in the figure, I, Hederacathichiside F; II, Tanguticoside B; III, Tauroside St-H₁；Ⅳ、3-O-β-D-allopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosylhederagenin28-O-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl ester；Ⅴ、Hederoside H₁；Ⅵ、kalopanaxsaponin G；Ⅶ、Hederasaponin B。

Detailed Description

The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

Example 1

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 5mL of 60% ethanol at 70 deg.C under reflux for 1 time and 2 hr each time, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, then extracting with 2 times of n-butanol for 2 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 15mg/mL solution with pure water, loading onto macroporous resin column X-5 at flow rate of 2BV/h, repeatedly loading the effluent into the column for 2 times, and standing for 6 h; removing impurities, eluting with 30% ethanol at flow rate of 4BV/h for 4 BV; enriching, selecting 40%, 60% and 80% ethanol concentration, eluting at flow rate of 4BV/h for 4BV to obtain 3 groups of elution fractions, and concentrating under reduced pressure to constant weight to obtain fine enriched powder of 3 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, wherein the adopted solvent systems are ethyl acetate-n-butanol-water (1:1:1, v: v: v) and ethyl acetate-n-butanol-water (4:1:2, v: v: v), the rotating speed of a main machine is 800rpm, the separation temperature is 30 ℃, the flow rate of a mobile phase is 2mL/min, and a head-tail or tail-head separation mode is adopted; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 70 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/4 inches, and the pipe diameter of the sample detection end is 250 micrometers; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester, and new saponin is prepared from 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylphenylethanyl-phenylethanoid 28-O-alpha-L-rhamnosyl (1 → 4) -beta-D-glucopyranosyl ester, and can be used as new saponinGlycosides were further confirmed using HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 2

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 70% ethanol at 60 deg.C under reflux at 10mL ratio for 2 times, each for 2 hr, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, then extracting with 3 times of n-butanol for 2 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 60mg/mL solution with pure water, loading onto macroporous resin column AB-8 at flow rate of 1BV/h, repeatedly loading the effluent into the column for 3 times, and standing for 10 h; removing impurities, eluting with 40% ethanol at a flow rate of 3BV/h for 3 BV; enriching, selecting 50% and 70% ethanol concentration, eluting at flow rate of 1BV/h for 8BV to obtain 2 groups of elution fractions, and concentrating under reduced pressure to constant weight to obtain fine enriched powder of 2 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, adopting solvent systems of ethyl acetate-n-butanol-water (1:2:2, v: v: v) and ethyl acetate-n-butanol-water (3:1:4, v: v: v), respectively, adopting a head-tail separation mode or a tail-head separation mode, wherein the rotating speed of a main machine is 600rpm, the separation temperature is 35 ℃, and the flow rate of a mobile phase is 1.5 mL/min; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 60 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/8 inches, and the pipe diameter of the sample detection end is 500 mu m; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new soap is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylfatty acid residue 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 3

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 15mL of ethanol with volume concentration of 75% at 80 deg.C under heating and refluxing for 3 times and 2 hr each time, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, extracting with 5 times of n-butanol for 3 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 30mg/mL solution with pure water, loading onto macroporous resin column HPD-100 at flow rate of 2BV/h, repeatedly loading the effluent into the column for 3 times, and standing for 12 h; removing impurities, and eluting with 30% ethanol at a flow rate of 2BV/h for 4 BV; enriching, selecting 40%, 50% and 60% ethanol concentration, eluting at flow rate of 2BV/h for 4BV to obtain 3 groups of elution fractions, and concentrating under reduced pressure to constant weight to obtain fine enriched powder of 3 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, adopting solvent systems of ethyl acetate-n-butanol-water (1:1:2, v: v: v) and ethyl acetate-n-butanol-water (4:1:4, v: v: v), respectively, adopting a head-tail separation mode or a tail-head separation mode, wherein the rotating speed of a main machine is 800rpm, the separation temperature is 35 ℃, and the flow rate of a mobile phase is 1.5 mL/min; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 80 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/16 inches, and the pipe diameter of the sample detection end is 250 micrometers; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl syl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY;the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 4

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 20mL of 80% ethanol at 90 deg.C under reflux for 1 time and 4 hr each time, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, extracting with 5 times of n-butanol for 1 time, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 45mg/mL solution with pure water, loading onto macroporous resin column ADS-7 at flow rate of 5BV/h, repeatedly loading the effluent into the column for 5 times, and standing for 8 hr; removing impurities, and eluting with 20% ethanol at a flow rate of 5BV/h for 8 BV; enriching, selecting 30%, 50%, 70% and 90% ethanol concentration, eluting at flow rate of 5BV/h for 5BV to obtain 4 groups of elution fractions, and concentrating under reduced pressure to constant weight to obtain fine enriched powder of 4 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, adopting solvent systems of ethyl acetate-n-butanol-water (2:2:3, v: v: v: v) and ethyl acetate-n-butanol-water (3:4:4, v: v: v: v), respectively, adopting a head-tail separation mode or a tail-head separation mode, wherein the rotating speed of a main machine is 1000rpm, the separation temperature is 40 ℃, and the flow rate of a mobile phase is 2.5 mL/min; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 90 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/16 inches, and the pipe diameter of the sample detection end is 100 mu m; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl syl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 5

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 30mL of 95% ethanol at 60 deg.C under reflux for 4 times (1 hr each time), mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, extracting with 1 volume of n-butanol for 5 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 45mg/mL solution with pure water, loading onto macroporous resin column HPD-400 at flow rate of 3BV/h, repeatedly loading the effluent into the column for 5 times, and standing for 2 h; removing impurities, namely eluting 1BV by adopting 0 percent of pure water at the flow rate of 1 BV/h; enriching, selecting 40%, 60% and 80% ethanol concentration, eluting at 1BV/h flow rate for 1BV respectively to obtain 3 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 3 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, adopting solvent systems of ethyl acetate-n-butanol-water (3:2:4, v: v: v: v) and ethyl acetate-n-butanol-water (3:1:3, v: v: v), respectively, adopting a head-tail separation mode or a tail-head separation mode, wherein the rotating speed of a main machine is 900rpm, the separation temperature is 25 ℃, and the flow rate of a mobile phase is 1 mL/min; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 60 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/4 inches, and the pipe diameter of the sample detection end is 500 mu m; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl syl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY; by structural identificationThe 7 saponin chemical reference substances are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 6

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 25mL of 85% ethanol at 75 deg.C under reflux for 2 times and 3 hr each time, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, extracting with 4 times of n-butanol for 3 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 7.5mg/mL solution with pure water, loading onto macroporous resin column HPD-450 at flow rate of 2BV/h, repeatedly loading the effluent into the column for 4 times, and standing for 4 h; removing impurities, eluting with 10% ethanol at a flow rate of 3BV/h for 3 BV; enriching, selecting 50% and 70% ethanol concentration, eluting at flow rate of 3BV/h for 3BV respectively to obtain 2 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 2 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, wherein the adopted solvent systems are ethyl acetate-n-butanol-water (1:1:3, v: v: v: v) and ethyl acetate-n-butanol-water (2:2:1, v: v: v), the rotating speed of a main machine is 600rpm, the separation temperature is 30 ℃, the flow rate of a mobile phase is 1mL/min, and a head-tail or tail-head separation mode is adopted; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 70 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/16 inches, and the pipe diameter of the sample detection end is 100 mu m; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl syl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 7

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 15mL of 65% ethanol at 65 deg.C under reflux for 4 times (1 hr each time), mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, extracting with 3 times of n-butanol for 4 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 15mg/mL solution with pure water, loading onto macroporous resin column HPD-100 at flow rate of 2BV/h, repeatedly loading the effluent onto the column for 1 time, and standing for 8 h; removing impurities, eluting with 40% ethanol at a flow rate of 2BV/h for 2 BV; enriching, selecting 40%, 60% and 80% ethanol concentration, eluting at flow rate of 2BV/h for 2BV respectively to obtain 3 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 3 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, wherein the adopted solvent systems are ethyl acetate-n-butanol-water (4:1:4, v: v: v: v) and ethyl acetate-n-butanol-water (2:1:2, v: v: v), the rotating speed of a main machine is 600rpm, the separation temperature is 30 ℃, the flow rate of a mobile phase is 3mL/min, and a head-tail or tail-head separation mode is adopted; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 80 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/8 inches, and the pipe diameter of the sample detection end is 250 micrometers; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; the 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyronylherehierarchy 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl syl (1 → 6) -beta-D-glucopyranosyl ester, and the new saponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure areOleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 8

The separation and preparation process of the saponin chemical reference substance in the tangut clematis comprises the following specific steps:

step 1, extraction: drying and crushing the whole herb of the clematis tangutica, mixing the dried and crushed herb with 1 g: extracting with 30mL of ethanol with volume concentration of 75% at 70 deg.C under heating and refluxing for 3 times, each for 3 hr, mixing extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude extract;

step 2, crude enrichment of n-butanol: suspending the crude extract in pure water, respectively extracting with petroleum ether and ethyl acetate until the upper phase has no color, then extracting with 4 times of n-butanol for 2 times, collecting all n-butanol extractive solutions, concentrating under reduced pressure, and freeze drying to obtain crude saponin extract;

step 3, fine enrichment of macroporous resin: loading, preparing the crude saponin extract into 15mg/mL solution with pure water, loading onto macroporous resin column ADS-7 at flow rate of 1BV/h, repeatedly loading the effluent into the column for 2 times, and standing for 6 h; removing impurities, and eluting with 20% ethanol at a flow rate of 2BV/h for 8 BV; enriching, selecting 50% and 70% ethanol concentration, eluting at flow rate of 2BV/h for 6BV respectively to obtain 2 groups of elution fractions, and concentrating under reduced pressure respectively to constant weight to obtain fine enriched powder of 2 groups of saponins;

and 4, high-speed countercurrent chromatographic separation: selecting 2 groups of the fine enriched powder of the saponin, respectively separating by adopting high-speed counter-current chromatography, adopting solvent systems of ethyl acetate-n-butanol-water (3:2:4, v: v: v: v) and ethyl acetate-n-butanol-water (1:2:2, v: v: v), respectively, adopting a head-tail separation mode or a tail-head separation mode, wherein the rotating speed of a main machine is 700rpm, the separation temperature is 35 ℃, and the flow rate of a mobile phase is 4 mL/min; detecting by adopting an evaporative light scattering detector ELSD (Electron cyclotron resonance spectroscopy), wherein the temperature of an atomizer is 60 ℃, and the flow rate of carrier gas is 2.5L/min; fractionating by adopting a self-made diverter valve system, wherein the self-made diverter valve system consists of a three-way valve and a fine-tuning valve positioned at a sample collection end, the pipe diameter of the sample collection end is 1/4 inches, and the pipe diameter of the sample detection end is 500 mu m; obtaining 7 saponin chemical reference substances; the purity of 7 saponin chemical reference substances is more than 98% by UPLC-ELSD analysis;

and 5, structural identification: passing the 7 saponin chemical reference substances through¹H-NMR、¹³And C-NMR is used for structural identification, wherein 6 known saponins are respectively as follows: hederacholithide F; tanguticoside B; tauroside St-H₁；Hederoside H₁(ii) a kalopanaxsaponin G; hederapasonin B; 1 new saponin is 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylhexetigenin 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester, and neosaponin is further confirmed by HMBC and NOESY; the 7 saponin chemical reference substances identified by the structure are oleanane type saponin compounds with similar structures.

The saponin chemical reference substance prepared by the invention has inhibitory activity on tumor cells, has no toxicity on normal epithelial cells, and can be used as an effective component to be applied to anti-tumor drugs; especially as an effective component in antitumor drugs for resisting gastric cancer, cervical cancer or ovarian cancer.

Example 9

The saponin chemical reference substances in the tangut clematis prepared in the examples 1 to 8 are taken to carry out the tumor cell strain (gastric cancer MGC-803 and HGC-27, ovarian cancer SK-OV-3 and cervical cancer Hela) inhibition activity test and the toxicity test on the normal gastric mucosa epithelial cell GES-1 cell strain.

1. Procedure of the test

(1) In vitro culture, passage and counting of cells

Cells were cultured in 1640 complete medium containing 10% FBS and 1% streptomycin at 37 ℃ in 5% CO₂Culturing in a wet incubator. When the cell fusion degree reaches more than 80%, the cells are passaged according to the ratio of 1: 5. Cell counting using a hemocytometerThe blood counting plate has an H-shaped groove, 2 counting pools with the height of 0.1mm are formed, each counting pool comprises 9 large squares, and the cell counting area is 4 large squares at four corners. Cell number 4 total cells/4 × 10 in large grid⁴X dilution factor. After the cell number is determined, the cell density can be adjusted according to the experiment requirement.

(2) The prepared chemical reference substance of the tangut clematis saponins has an influence experiment on gastric cancer cell strains MGC-803 and HGC-27, ovarian cancer cell strains SK-OV-3, cervical cancer Hela and normal gastric mucosa epithelial cells GES-1. Wherein, gastric cancer cell HGC-27, cervical cancer cell Hela and ovarian cancer cell SK-OV-3 are purchased from Wuhan Punuoise Life technologies GmbH, gastric cancer cell MGC-803 and normal gastric mucosa epithelial cell GES-1 are purchased from Beinaner biological cell bank.

2. Experimental methods

(1) Selecting cells in logarithmic growth phase, adjusting cell suspension concentration, inoculating to 96-well culture plate with 100 μ L/well, allowing temperature to be 37 deg.C, and allowing 5% CO₂The cell fusion rate reaches 80 percent when the cells are cultured in a humid incubator for 24 hours.

(2) Removing original culture medium, washing with PBS once, adding culture medium containing chemical reference substances of different concentrations (10, 45, 80, 115, 150 μ M) of tangut clematis saponins with concentration of 100 μ L, 37 deg.C, and 5% CO₂The wet incubator is used for 48 hours. Cisplatin was used as a positive control. Each group was provided with 5 holes as parallels.

(3) mu.L of freshly prepared MTT solution (5mg/mL) was added to each well and incubated for 4h in the absence of light.

(4) The culture was terminated by carefully aspirating the supernatant, adding 150. mu.L of DMSO to each well, shaking the mixture on a shaker for 15min at low speed to dissolve the crystals sufficiently, and measuring the absorbance (OD) of each well at 540nm using a microplate reader. The cell growth inhibition rate was calculated and the results were expressed as mean. + -. SD (standard deviation). GraphPad software for IC₅₀Fitting of values.

Cell growth inhibition rate (1-OD)_{Experimental group}/OD_{Blank control})×100％

3. Results of the experiment

The prepared chemical reference substance pair 5 of the tangut clematis saponinsThe results of the effect of the seed cell lines are detailed in Table 1. Wherein, the new saponin chemical reference 3-O-beta-D-allopyranosyl (1 → 3) -alpha-L-rhamnopyranosyl (1 → 2) -alpha-L-arabinopyranosylhectographin 28-O-alpha-L-rhamnopyranosyl (1 → 4) -beta-D-glucopyranosyl (1 → 6) -beta-D-glucopyranosyl ester and saponin Hederacholethiside F have selective inhibitory activity on gastric cancer cell HGC-27, IC is IC₅₀The values were 20.17 and 66.18. mu.M, respectively, indicating that the presence of D-allose or a branched sugar chain on the substituent at the C-3 position of the oleanane-type triterpene saponin may enhance the inhibitory activity against tumor cells. The saponin Hederaponin B has broad-spectrum inhibitory effect (IC) on gastric cancer cell HGC-27, cervical cancer cell Hela and ovarian cancer cell SK-OV-3₅₀16.4, 71.3, 64.4 μ M, respectively), and saponin Hederoside H₁Under the measured concentration, no obvious inhibition activity is shown on four tumor cell strains (gastric cancer cell strains MGC-803 and HGC-27, ovarian cancer cell strain SK-OV-3 and cervical cancer Hela). Saponin Hederoside H₁The only difference from Hedera aponin B structure is that the C-4 position of the former is-CH₃and-OH substitution, the latter being two-CH in the C-4 position₃Substitution, which indicates the presence of two-CHs at C-4₃Can obviously increase the tumor cell inhibiting activity. In addition, the saponin Tauroside St-H₁Shows selective inhibitory activity against ovarian cancer cell line SK-OV-3, IC₅₀The value was 48.70. mu.M. All isolated saponins are non-toxic to normal gastric mucosal epithelial cells GES-1 (IC)₅₀>150μM)。

TABLE 1 antitumor cell Activity of chemical controls for tangut clematis saponins

Example 10

1. Optimization experiment of enrichment process of saponin components in tangut clematis

(1) Static adsorption experiment selection of macroporous adsorption resin

Taking 6 pretreated resins (HPD-100, X-5, HPD-400, AB-8, HPD-450 and ADS-7, equivalent to 1g of dry weight), respectively placing in a 100mL triangular flask with a plug, respectively adding 25mL of each of the crude saponins of the clematis tangutica 30mg/mL, plugging the plug, taking 25mL of the crude saponins of the clematis tangutica without the resin as a reference, placing in a constant temperature oscillator, oscillating for 12h, and fully adsorbing, and taking each group of solution to determine the content of the saponins. And filtering the mixed solution in each bottle to remove the solution, placing the resin absorbed with the sample in a conical flask, adding 25mL of 95% ethanol-water, plugging a bottle stopper, placing in an oscillator for oscillation for 2h, and determining the saponin content in each resin analytic solution. Each set was set to 3 replicates. And respectively calculating the adsorption quantity and the adsorption rate according to formulas I and II.

In the formula, A_eAs dry resin adsorption (mg/g); c₀And C₁Respectively representing the initial concentration and the adsorption equilibrium concentration (mg/mL) of total saponins in a sample solution; v₁Sample solution volume (mL); d_dAs desorption rate (%); c₂The total saponin concentration (mg/mL) of the desorption solution is obtained; v₂Volume of stripping solution (mL).

(2) Dynamic adsorption and desorption experiments

A glass column (2.5 cm. times.45 cm) was wet-packed with the pretreated hydrated resin (5g of dry resin) to conduct dynamic adsorption and desorption tests. The column volume was about 30 mL.

Optimization of concentration of sample solution

The crude saponin solution of the clematis tangutica is adopted for loading with the concentration of 7.5, 15, 30, 45 and 60mg/mL respectively, and the loading volume (240-30mL) is changed to ensure the same loading amount. Adsorbing for the same time, removing excessive sample with pure water, eluting with 70% ethanol with an elution volume of 5BV, collecting eluate, determining total saponin concentration in the eluate at different sample concentrations, and selecting the optimal initial concentration of sample.

② selection of concentration of eluent

70mL of 30mg/mL of the crude saponin solution of clematis tangutica was loaded on a resin column, and washed with pure water, 10%, 20%, 30%, 40%, 50%, 60% and 70% ethanol in this order, and the elution volume was 5 BV. Collecting eluates of ethanol with different concentrations, concentrating, drying and weighing. And measuring the purity (%, mg/mg) of the total saponins at different elution parts, namely the mass concentration, and calculating the weight of the total saponins at different elution parts according to a formula III.

Y＝m×P③

Wherein Y (mg) is the weight of total saponins at different elution sites; m (mg) is the weight of the different sites; p (%, mg/mg) is the purity of total saponins at different sites.

Optimization of volume of eluent

70mL of a crude saporin solution of clematis tangutica (30mg/mL, corresponding to 8.74mg/mL of total saponins) was loaded onto a resin column, and the non-adsorbed sample was first removed with 5BV of pure water, followed by studies using 30% and 70% ethanol at different elution volumes (1, 2, 3, 4, 5, 6, 7, 8BV), respectively. Concentrating different elution parts, measuring the weight of total saponin at different parts, and selecting the optimal volume of the eluate.

2. Optimization result of enrichment process of saponin components in tangut clematis

(1) Screening for suitable resins

The selection of macroporous resins with strong adsorption and desorption properties is a key step for the effective enrichment of target compounds. The tangut clematis saponins compounds are generally composed of nonpolar aglycone and polar sugar chains, which shows that nonpolar resin, weak polar resin and polar macroporous resin can be used for enriching tangut clematis saponins components. The adsorption capacity and desorption rate of six saponins (HPD-100, X-5, HPD-400, AB-86, HPD-450 and ADS-7) on the target saponin compound are studied, and the results are shown in figure 14. The results show that the nonpolar HPD-100(91.5mg/g, 91.6%) and polar ADS-7(91.3mg/g, 87.9%) have higher adsorption and desorption rates than other resins. Presumably, the nonpolar aglycone and polar sugar chain of the tangut clematis saponins play an important role in the resin adsorption process. Considering the relatively low price of HPD-100, HPD-100 was finally selected for subsequent experiments.

(2) Effect of initial loading concentration

As shown in figure 15, the adsorption capacity of the resin to the total saponins of clematis tangutica was gradually enhanced during the increase of the sample loading concentration from 7.5mg/mL to 30mg/mL, and reached the maximum value when the sample solution concentration was 30 mg/mL. However, with further increase of the loading concentration, the adsorption capacity of the resin to the total saponins is slightly reduced. This phenomenon can be explained as a large sample loading volume and a long sample loading time are needed when the sample loading concentration is too low, and the sample is easily lost in the process; when the loading concentration is too high, adsorption of impurities by the resin may also result in a weakening of the adsorption ability to the target saponin component. Therefore, the sample concentration of the glaucomatous saponin of 30mg/mL is finally selected for the subsequent enrichment and purification process.

(3) Influence of ethanol concentration on enrichment effect

The results of the quality, purity and content determination of total saponins of the eluent concentrates with different ethanol concentrations are shown in fig. 16. The purity and content of the total saponin are obviously increased along with the increase of the ethanol concentration, the purity and content of the total saponin are respectively 63.6%, 70.7% and 63.3% when the ethanol concentration is 40%, 50% and 60%, and the purity and content of the total saponin are respectively 542.5, 227.1 and 130.4mg when the total saponin is eluted by 70% and 80% ethanol, and the purity and content of the total saponin are reduced. The total saponins 10%, 20%, 30% and 80% ethanol eluate concentrate have a mass of 122.3, 160.2, 216.1 and 14.2mg, respectively, but the total saponins content is only 6.9, 10.2, 19.8 and 3.7 mg. Therefore, from the viewpoint of high-efficiency enrichment and reagent saving, 30% ethanol is selected as an impurity removal reagent to remove non-saponin impurities, and then 70% ethanol is used as an elution solvent to enrich total saponins.

(4) Effect of elution volume results

After the adsorption is completed, removing impurities and eluting with 30% and 70% ethanol in sequence, and examining the influence of elution volumes of 1, 2, 3, 4, 5, 6, 7 and 8BV on the enrichment effect. First, 30% ethanol was used to remove the non-saponin impurities. As shown in FIG. 17, when the amount of 30% ethanol eluent was 1-4BV, the dried product of the eluent was 63.0, 164.6, 83.8, 43.3mg in mass and the purity was 4.85%, 7.80%, 7.13% and 7.70%, respectively. When the elution is continued to reach 5-8BV, the purity of the total saponin in the elution product of each column volume is 17.9%, 6.9%, 15.6% and 15.9% respectively. Therefore, for the purpose of maximizing the removal of non-saponin impurities while avoiding the loss of the target saponin components, 4BV of 30% ethanol was selected as the optimal impurity removal reagent. In the second step, the effect of different volumes of 70% ethanol on the enrichment effect was examined. When 70% ethanol of an elution volume of 1-2BV was used for elution, 436.2mg and 468mg of eluted product were obtained, respectively, and the total saponins contained therein had a purity of 61.3% and 63.7%, respectively. When the elution volume is 3-4BV, the product mass is 76.3mg and 78.2mg, and the saponin purity is 63.9% and 53.1%, respectively. When the elution volume was from 5BV to 8BV, 49.1, 38.2, 32.7 and 17.7mg samples were obtained, all with less than 25% purity. Therefore, 4BV of 70% ethanol was finally selected as the optimal elution volume from the viewpoint of saving reagents and enriching high purity high yield saponin samples.

Example 11

Optimization experiment of HSCCC separation System for Saponin ingredients in Nothapodytes tangutica prepared in examples 1-8

A solvent system consisting of ethyl acetate/n-butanol/water was optimized by analyzing the partition coefficient (K) of the target compound in a two-phase solvent system. A suitable amount of sample powder was dissolved in a series of biphasic solvent systems of different proportions, and shaken vigorously to bring the sample to complete equilibrium between the two phases. The same volume of the upper and lower phases was taken, the solvent was evaporated to dryness and the residue was dissolved in 2mL of methanol and analyzed by HPLC-ELSD. K is A_{Upper phase}/A_{Lower phase}Wherein A is_{Upper phase}And A_{Lower phase}Representing the peak areas of the target compound in the upper and lower phases, respectively. K values of the target compound in different ratios of ethyl acetate/n-butanol/water systems are shown in Table 2. If the K value is too small, the compound willIs eluted rapidly, a plurality of compounds are overlapped, and the elution time is prolonged obviously by the over-high K value, and the peak shape is wider. In general, the K value should be in the range of 0.2 to 5, the separation factor (α ═ K) of the two compounds₂/K₁，K₂>K₁) Should be greater than 1.5 to achieve a good separation effect and a suitable separation time. The distribution of 7 saponin controls in different two-phase solvent systems is shown in table 2. Finally, ethyl acetate/n-butanol/water (v/v/v, 2:2:4) and ethyl acetate/n-butanol/water (v/v/v, 4:1:4) are selected as the optimal solvent systems for separating the triterpene saponin at 40% and 60% ethanol elution parts.

TABLE 2K values of the target compounds

Example 12

The structural identification data for the new compounds are as follows:

a white powder; m.p.220.3-221.2 ℃;UV(H₂O)：λ_max＝191nm；IR(KBr)：ν_max＝3382，2930，1729，1637，1450，1381，1365，1256，1232，1028cm^-1(ii) a HR-ESI-MS gives the peak M/z 1381.6624[ M-H ] of the excimer ion]^-(calculated value 1381.6628) and formula C₆₅H₁₀₆O₃₁. In deuterated pyridines¹H and ¹³The C nuclear magnetic data are shown in table 3. The results of HMBC and NOSEY are shown in FIG. 12.

TABLE 3 novel Compounds in deuterated pyridines¹H and ¹³C nuclear magnetic data

Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.